Abstract: This present invention is a novel method and wearable device for stimulating positive DNA gene expression and mitigating negative DNA gene expression in order to improve health and wellness. The invention's unique characteristics include the application of multiple modalities, their unique configuration for safe, low-power application, the wearable device's unique arrangement in a flat, flexible configuration for elastic contouring with comfort required for an extended period of wearing, and the ability to optimize and personalize the parameters and mixing among such modalities. The invention further combines biometric feedback data with Artificial Intelligence analytic capabilities, to facilitate the identification and characterization of DNA resonant frequencies, and associated “stimulus-response” modeling associated with such biological interactions.

Abstract: Some aspects of the present invention include a system for computationally prediction of oscillation patterns of charges in a DNA sequence. Such a system includes one or more means for computationally predicting proton wires with longitudinal (coaxial) hydrogen bonds in the DNA sequence; and at least one means for predicting electron wires in the DNA sequence. These wires connect the aromatic rings of DNA basepairs. The above system includes at least one means for predicting tautomeric oscillations in said DNA. A method according to some aspects of the present invention for computationally predicting oscillation pattern of charges in a DNA sequence includes: computationally predicting proton wires containing longitudinal (coaxial) hydrogen bonds, the wires spanning at least two DNA basepairs; predicting electron wires in the DNA which includes stretches of purines; and predicting tautomeric oscillations in the DNA.

Abstract: The present invention generally relates to a method and system of DNA resonance and its applications. In particular, the present invention provides a method and system of DNA resonance measurement which is done non-chemically. The invention is a device using an impedance spectroscopy and analyzing it to produce the diagnostic profile of the health and using initial treatments to see how the profile change and then adjusting the treatment to improve the profile in a specific direction, adjusting the parameters of the electric, electromagnetic and sound treatment for better outcomes. In this invention, the initial treatment is at 42.2 Gigahertz, which leads to Alu sequence decompaction and activation of the DNA leading to the improved biological outcomes, improved coherence and orderliness of the DNA and of the DNA fractal patterns.

Abstract: This present invention is a novel method and wearable device for stimulating positive DNA gene expression and mitigating negative DNA gene expression in order to improve health and wellness. The invention's unique characteristics include the application of multiple modalities, their unique configuration for safe, low-power application, the wearable device's unique arrangement in a flat, flexible configuration for elastic contouring with comfort required for an extended period of wearing, and the ability to optimize and personalize the parameters and mixing among such modalities. The invention further combines biometric feedback data with Artificial Intelligence analytic capabilities, to facilitate the identification and characterization of DNA resonant frequencies, and associated “stimulus-response” modeling associated with such biological interactions.

Abstract: The present invention is a novel method of preparing copper sheeting for exposure to UV or optical light in the process of manufacturing flexible printed circuit boards. This method seeks to remove the need for the highly complex, costly, and capital-intensive use of collimated UV lights and vacuum chambers in conventional FPCB manufacturing by preparing copper sheeting for non-vacuum non-collimated UV exposure with a relatively trivial method using clear vinyl stickers, conventional toner-adhering decorative foil, and UV reflective glue. This in turn will “democratize” the design, development, fabrication, production, and distribution of advanced electronics that depend upon the use of high-precision FPCBs.

Abstract: Method and system of DNA resonance and its applications which is done non-chemically using impedance spectroscopy and analyzing it to produce the diagnostic profile of the health and using initial treatments to see how the profile change and then adjusting the treatment to improve the profile in a specific direction, adjusting the parameters of the electric, electromagnetic and sound treatment for better outcomes. The initial treatment is at 42.2 Gigahertz, which leads to Alu sequence decompaction and activation of the DNA leading to improved biological outcomes, improved coherence, and orderliness of the DNA and of the DNA fractal patterns. Further, the present invention is intended to various applications such as in therapy, communication to and from the body, communication to and from the brain, biotechnology and biological research using electromagnetic waves, patterned electric voltage, magnetic pulses, sound or other such means of stimulation applied individually and/or in combinations.